Bayer picks up off-the-shelf CAR-T approach from Atara, spotlighting a Memorial Sloan Kettering breakthrough

Bayer’s brand new cell & gene therapy strategy now also features CAR-T.

In a new deal with Atara Biotherapeutics, the German pharma has reserved …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bay­er picks up off-the-shelf CAR-T ap­proach from Atara, spot­light­ing a Memo­r­i­al Sloan Ket­ter­ing break­through